Abstract: The disclosure relates to LILRB2 antibody products and methods of use thereof. The antibody products specifically bind to LILRB2 on cells such as myeloid cells or cancer cells. The antibody products can be used in methods of treatment of disease, such as methods cancer immunotherapy.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: The present disclosure relates to a piston diaphragm seal for transmitting a pressure of a medium to a pressure-measuring sensor a base body having a recess and a bore which is connected to the recess. The recess and the bore can be filled with a pressure transfer medium. A piston is arranged in the recess and can be moved within a predetermined region in the recess. A surface of the piston facing the medium can be loaded with the pressure of the medium, wherein the piston is separated by at least two sealing elements from the medium and the pressure transfer medium. A cavity is arranged in the piston between the at least two sealing elements. An attachment region is provided for connecting the piston diaphragm seal to the pressure-measuring sensor. A monitoring unit is designed to determine and/or monitor entry of medium and/or pressure transfer medium into the cavity.

Abstract: Provided herein are uses of antibodies that bind to CD163 expressed on a human myeloid cell in combination with checkpoint inhibitors. Among other things, these CD163 antibodies can be used with checkpoint inhibitors in methods of treatment of humans, such as methods of treating a cancer or methods of relieving T cell suppression.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Abstract: The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.

Abstract: The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.

Abstract: A seat rail for a vehicle seat of a motor vehicle, including a seat rail profiled element, which has at least one profile region into which at least one corresponding retaining element of the vehicle seat can be inserted in at least one retaining position. The seat rail includes at least one ramp element extending at an angle from the longitudinal extension of the seat rail profiled element, by which ramp element the retaining element can be moved out of the profile region from the retaining position to at least one removal position by moving the retaining element along the ramp element.

Abstract: A seat rail for a vehicle seat of a motor vehicle, including a seat rail profiled element, which has at least one profile region into which at least one corresponding retaining element of the vehicle seat can be inserted in at least one retaining position. The seat rail includes at least one ramp element extending at an angle from the longitudinal extension of the seat rail profiled element, by which ramp element the retaining element can be moved out of the profile region from the retaining position to at least one removal position by moving the retaining element along the ramp element.

Abstract: Instructions within a processor are managed by receiving, at a recovery unit of the processor, an instruction that modifies a control register residing within the recovery unit. The recovery unit receives a first set of data associated with the instruction from a general register. A second set of data associated with the instruction is retrieved from the control register by the recovery unit. The recovery unit performs at least one binary logic operation on the first set of data and the second data.

Abstract: The present invention relates to compositions comprising proteins or polynucleotides of Chlamydia sp., in particular combinations of proteins or polynucleotides encoding them, and methods for the use of the proteins or polynucleotides in the treatment, prevention and diagnosis of Chlamydia infection.

Abstract: The present invention relates to compositions comprising proteins or polynucleotides of Chlamydia sp., in particular combinations of proteins or polynucleotides encoding them, and methods for the use of the proteins or polynucleotides in the treatment, prevention and diagnosis of Chlamydia infection.

Abstract: Provide herein are fusion polypeptides that comprise a CD47 extracellular domain or a variant thereof that is fused to a Fc polypeptide. The fusion polypeptides are useful for treating an immunological disease or disorder in a subject according to the methods described herein. The fusion polypeptides are capable of suppressing immunoresponsiveness of an immune cell, inhibiting production of proinflammatory cytokines, including inhibiting immune complex-induced production of cytokines.

Abstract: Instructions within a processor are managed by receiving, at a recovery unit of the processor, an instruction that modifies a control register residing within the recovery unit. The recovery unit receives a first set of data associated with the instruction from a general register. A second set of data associated with the instruction is retrieved from the control register by the recovery unit. The recovery unit performs at least one binary logic operation on the first set of data and the second data.

Abstract: Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Chlamydial infection in patients and in biological samples.